Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
28.66
+0.84 (3.02%)
At close: Mar 9, 2026, 4:00 PM EDT
28.62
-0.04 (-0.14%)
After-hours: Mar 9, 2026, 7:45 PM EDT
Edgewise Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 3,074 | 2,627 | 2,528 | 694 | 565 | 753 | |
| Market Cap Growth | 19.81% | 3.91% | 264.15% | 22.85% | -24.97% | - | |
| Enterprise Value | 2,548 | 2,068 | 2,040 | 410 | 203 | 463 | |
| Last Close Price | 28.66 | 24.82 | 26.70 | 10.94 | 8.94 | 15.28 | |
| PB Ratio | 5.83 | 5.03 | 5.51 | 2.18 | 1.63 | 2.75 | |
| P/TBV Ratio | 5.89 | 5.03 | 5.51 | 2.18 | 1.63 | 2.75 | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | - | |
| Net Debt / Equity Ratio | -1.01 | -1.01 | -1.01 | -0.98 | -1.00 | -1.02 | |
| Net Debt / EBITDA Ratio | 2.78 | 2.78 | 2.97 | 2.77 | 4.88 | 6.54 | |
| Net Debt / FCF Ratio | 3.65 | 3.65 | 4.22 | 3.20 | 5.97 | 8.22 | |
| Quick Ratio | 19.37 | 19.37 | 19.70 | 18.99 | 21.22 | 26.69 | |
| Current Ratio | 19.85 | 19.85 | 19.93 | 19.50 | 21.53 | 26.97 | |
| Return on Equity (ROE) | -34.19% | -34.19% | -34.40% | -30.10% | -21.78% | -21.34% | |
| Return on Assets (ROA) | -23.02% | -23.02% | -24.01% | -20.21% | -13.73% | -12.97% | |
| Return on Capital Employed (ROCE) | -36.40% | -36.40% | -34.30% | -35.40% | -20.40% | -15.70% | |
| Earnings Yield | -5.46% | -6.39% | -5.29% | -14.43% | -11.97% | -5.68% | |
| FCF Yield | -4.69% | -5.48% | -4.36% | -14.07% | -10.29% | -4.54% | |
| Buyback Yield / Dilution | -11.38% | -11.38% | -45.02% | -18.90% | -42.82% | -4977.96% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.